# Clinical Study to Assess a New Barrier Film's Ability to Provide Skin Protection Against Incontinence & Allow Healing

> **NCT02570139** · NA · TERMINATED · sponsor: **Solventum US LLC** · enrollment: 45 (actual)

## Conditions studied

- Incontinence Associated Dermatitis

## Interventions

- **DEVICE:** Cavilon Advanced Skin Protectant
- **DEVICE:** ConvaTec Sensi-Care Protective Barrier

## Key facts

- **NCT ID:** NCT02570139
- **Lead sponsor:** Solventum US LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-10
- **Primary completion:** 2017-06-23
- **Final completion:** 2017-06-23
- **Target enrollment:** 45 (ACTUAL)
- **Why stopped:** Low enrollment, short stay; lacked statistically powered evaluation for efficacy.
- **Last updated:** 2024-10-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02570139

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02570139, "Clinical Study to Assess a New Barrier Film's Ability to Provide Skin Protection Against Incontinence & Allow Healing". Retrieved via MORVS 2026-09-29 from https://api.morvs.ai/clinical/NCT02570139. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*